(HealthDay)—People newly infected with COVID-19 might soon have access to what essentially is Tamiflu for the novel coronavirus, a breakthrough that experts say would drastically alter the course of the ongoing pandemic. At least three contenders are vying to become…
Read More
Racial gap eliminated in US COVID vaccinations: survey
The racial gap in the United States’ COVID vaccination campaign has been eliminated while the partisan divide continues to loom large, according to a highly-cited survey published Tuesday. The Kaiser Family Foundation (KFF) COVID Vaccine Monitor, which conducted a nationally…
Read More
AWS pledges focus on underserved communities with new $40M initiative
Amazon Web Services on Monday announced the launch of a new initiative to help organizations worldwide build IT-powered social and healthcare programs to help patients in underserved communities. WHY IT MATTERS AWS is pledging $40 million over three years…
Read More
Doctors divided over use of controversial new Alzheimers drug
(HealthDay)—The controversial new Alzheimer’s drug Aduhelm is creating something of a civil war in medicine, as health networks, hospitals, insurers and individual doctors weigh impending discussions with patients about whether they should take the medication. Many doctors believe the U.S….
Read More
One vaccine dose enough for COVID-19 survivors
Two mRNA vaccines against COVID-19 have proven safe and effective in clinical trials, as well as in the millions of people who have been vaccinated so far. But how prior SARS-CoV-2 infection affects vaccine response, and how long that response…
Read More
Delta Covid symptoms: Millions of vaccinated people are likely to share one common sign
India: Experts warn of 'third coronavirus wave' in Autumn When you subscribe we will use the information you provide to send you these newsletters. Sometimes they’ll include recommendations for other related newsletters or services we offer. Our Privacy Notice explains…
Read More
In poorest countries, surge combines with vaccine shortage
Hati Maronjei once swore he would never get a COVID-19 shot, after a pastor warned that vaccines aren’t safe. Now, four months after the first batch of vaccines arrived in Zimbabwe, the 44-year-old street hawker of electronic items is desperate…
Read More
Study offers overview of SARS-CoV-2 infection in children
While the current pandemic of coronavirus disease 2019 (COVID-19) has largely spared children from severe illness, relative to adults, its causative pathogen – the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – can still cause infection and post-acute sequelae in…
Read More
Patients with mild cases of COVID-19 may have LIFELONG protection
Patients with mild cases of COVID-19 still have antibodies 11 months after infection and may even have LIFELONG protection, study suggests A new study looked at blood samples from 77 patients who previously had mild cases of COVID-19 Antibody levels…
Read More
New DNA research could help combat cancers resistant to current treatments
In a groundbreaking first, research led by Queen’s University Belfast has found thousands of “Achilles Heels’ or ‘cancer vulnerabilities’ in an analysis of more than 700 different cancer cell types. In the future, this could lead to new ways to…
Read More